Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 17, 2025

Cycurion Reports Full Year 2024 Financial Results
MCLEAN, Va., April 17, 2025 (GLOBE NEWSWIRE) -- Cycurion (Nasdaq: CYCU) (“Cycurion” or the “Company”), a trusted leader in IT cybersecurity solutions and AI, reports financial results for full year ended December 31, 2024, and provides a corporate update …

Olon erhält CMO Excellence in Green Chemistry Award 2025
RODANO, Italien, April 17, 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. freut sich, die Verleihung des renommierten CMO Excellence in Green Chemistry Award 2025 bekanntzugeben. Diese Auszeichnung, die vom ACS Green Chemistry Institute Pharmaceutical Roundtable ( …

Olon se voit décerné le Prix d’excellence CMO en chimie verte en 2025
RODANO, Italie, 17 avr. 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. a l’honneur d’annoncer qu’elle a reçu le prestigieux Prix d’excellence CMO en chimie verte (CMO Excellence in Green Chemistry Award) en 2025. Décernée par l’ACS Green Chemistry Institute …

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior
Vancouver, Canada, April 17, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …

Intermap Announces Dates for First Quarter Earnings and AGM
Company will announce first quarter 2025 financial results and host a conference call on May 15, 2025 Company will host its Annual General Meeting on June 26, 2025 DENVER, April 17, 2025 (GLOBE NEWSWIRE) -- Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“ …

ZenaTech to Showcase Drone as a Service (DaaS) and AI Drone Innovation for Commercial and Defense Markets at Two Premier Investor Conferences — D. Boral Capital Conference and Ladenburg Technology Innovation Expo25
VANCOUVER, British Columbia, April 17, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and …

uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease
~ Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~ ~ Additional regulatory update and guidance on the Biologics License Application submission expected in the second …

EYLEA HD® (aflibercept) Injection 8 mg sBLA Accepted for FDA Priority Review for Both the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing in Approved Indications
If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are indicated for all other anti-VEGF therapies Potential for as …

Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025
CAMBRIDGE, Mass., April 17, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced the company will host a conference …

Atana Recognized for Innovation and Technology in Ragan’s 2025 Employee Communications Awards
BELLEVUE, Wash., April 17, 2025 (GLOBE NEWSWIRE) -- Seeking to redefine workplace culture and training, Atana is proud to announce that it has been named a winner in Ragan’s Employee Communications Awards. The Innovation and Technology Award for HR Tool/ …

Tilray Brands Announces Proposed Reverse Stock Split and Corresponding Special Meeting of Stockholders
NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness …

Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea” or “Company”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today …

Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory Conditions
Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy volunteers in Q2 2025 GS-6791/NX-0479 has potential clinical applications across multiple blockbuster markets in …

Cryptocurrency trends and policies are connected, SIX MINING stands at the "new outlet"
London, UK, April 17, 2025 (GLOBE NEWSWIRE) -- If El Salvador is integrating the country into the Bitcoin ecosystem through policy means, then SIX MINING represents the civil power of cryptocurrency technology application. The platform not only deploys …

Signing Day Sports/U.S. Army Bowl Combines Provide Recruitment Opportunities, Draw Strong Participation
SCOTTSDALE, AZ, April 17, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform, today provided an in-season update on the 2025 Military …

Interius BioTherapeutics to Present at Upcoming Scientific Meetings
PHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- Interius BioTherapeutics, a clinical-stage company engineering targeted, programmable vectors for the precision delivery of genetic medicines, today announced that it will present at several upcoming …

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics
Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching Pelthos’ ZELSUVMI™ ZELSUVMI is an FDA-designated novel drug and the first and only prescription medication approved …

Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025
VANCOUVER, British Columbia, April 17, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …

Ragnarok: Back to Glory Official Launching in Korea and Southeast Asia on April 17, 2025
Seoul, South Korea, April 17, 2025 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, announced the official launch of Ragnarok: Back to Glory, in Korea and Southeast Asia …

Verano Elevates Florida Retail Footprint to 81 Dispensaries with the Opening of MÜV New Smyrna Beach
Dispensary to celebrate 420 “high holiday” opening weekend with plethora of deals and discounts available at all Florida MÜV locations Located at 763 East 3rd Avenue, MÜV New Smyrna Beach is Verano’s fourth MÜV location in Florida’s Volusia County, a …